Analysts See $-0.01 EPS for Pharma-Bio Serv, Inc. (PBSV)

May 17, 2018 - By Hazel Jackson

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) Logo

Analysts expect Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) to report $-0.01 EPS on June, 13.They anticipate $0.00 EPS change or 0.00 % from last quarter’s $-0.01 EPS. It closed at $0.6 lastly. It is down 0.00% since May 17, 2017 and is . It has underperformed by 11.55% the S&P500.

Pharma-Bio Serv, Inc., a compliance and technology transfer services consulting company, provides compliance consulting services to the pharmaceutical, biotechnology, medical device, and chemical manufacturing companies in Puerto Rico, the United States, Europe, and Brazil. The company has market cap of $13.84 million. The companyÂ’s technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. It currently has negative earnings. It also provides microbiological testing services and chemical testing services through its laboratory; and technical trainings/seminars.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.